【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of Markets/Categories Covered 14
3.1 In Vitro Diagnostics 14
3.1.1 Immuno Chemistry 14
3.1.2 Infectious Immunology 14
4 Company Snapshot 15
4.1 Key Information 15
4.2 Company Overview 15
4.3 Financial Performance 15
4.4 SWOT Snapshot 15
4.5 Business Overview 16
4.6 Major Products and Services 17
4.6.1 Overview 17
5 History 19
6 SWOT Analysis 25
6.1 Overview 25
6.2 PerkinElmer, Inc. Strengths 25
6.2.1 Diversified Geographic Presence 25
6.2.2 Strong Research and Development Capabilities 25
6.2.3 Continuous Product Innovations 26
6.3 PerkinElmer, Inc. Weaknesses 26
6.3.1 Increasing Trade Receivables 26
6.3.2 Increasing Operating Expenses 26
6.4 PerkinElmer, Inc. Opportunities 27
6.4.1 Strategic Collaborations 27
6.4.2 Inorganic Growth Strategy 27
6.4.3 Growth in Emerging Markets 27
6.5 PerkinElmer, Inc. Threats 28
6.5.1 Industry Consolidation Challenges 28
6.5.2 Rapid Technological Change 28
6.5.3 Uncertain R&D Outcomes 28
7 Competitors 29
8 Competitive Landscape 30
8.1 In Vitro Diagnostics (Immuno Chemistry), Global, Market Share (%), 2011 30
8.2 PerkinElmer, Inc, In Vitro Diagnostics (Immuno Chemistry), by Region, Market Share (2011) 32
8.3 PerkinElmer, Inc, In Vitro Diagnostics (Immuno Chemistry), by Country, Market Share (2011) 33
8.4 In Vitro Diagnostics (Infectious Immunology), Global, Market Share (%), 2011 35
8.5 PerkinElmer, Inc, In Vitro Diagnostics (Infectious Immunology), by Region, Market Share (2011) 37
8.6 PerkinElmer, Inc, In Vitro Diagnostics (Infectious Immunology), by Country, Market Share (2011) 38
9 PerkinElmer, Inc. Medical Equipment Market Share Analysis by Category 40
9.1 PerkinElmer, Inc., In Vitro Diagnostics, Global, Category Revenue Share (2011) 40
9.2 PerkinElmer, Inc., Asia-Pacific, Category Revenue Share (2011) 42
9.2.1 PerkinElmer, Inc., Australia, Category Revenue Share (2011) 44
9.2.2 PerkinElmer, Inc., China, Category Revenue Share (2011) 45
9.2.3 PerkinElmer, Inc., Japan, Category Revenue Share (2011) 47
9.2.4 PerkinElmer, Inc., Other Asia-Pacific, Category Revenue Share (2011) 49
9.3 PerkinElmer, Inc., Europe, Category Revenue Share (2011) 51
9.3.1 PerkinElmer, Inc., France, Category Revenue Share (2011) 53
9.3.2 PerkinElmer, Inc., Germany, Category Revenue Share (2011) 55
9.3.3 PerkinElmer, Inc., Italy, Category Revenue Share (2011) 57
9.3.4 PerkinElmer, Inc., Spain, Category Revenue Share (2011) 59
9.3.5 PerkinElmer, Inc., United Kingdom, Category Revenue Share (2011) 61
9.3.6 PerkinElmer, Inc., Other Europe, Category Revenue Share (2011) 63
9.4 PerkinElmer, Inc., Middle East and Africa, Category Revenue Share (2011) 65
9.5 PerkinElmer, Inc., North America, Category Revenue Share (2011) 67
9.5.1 PerkinElmer, Inc., Canada, Category Revenue Share (2011) 69
9.5.2 PerkinElmer, Inc., United States, Category Revenue Share (2011) 71
9.6 PerkinElmer, Inc., South and Central America, Category Revenue Share (2011) 73
9.6.1 PerkinElmer, Inc., Brazil, Category Revenue Share (2011) 75
9.6.2 PerkinElmer, Inc., Other South and Central America, Category Revenue Share (2011) 76
10 Key Employees 78
11 Key Employee Biographies 79
12 Company Statement 80
13 Locations And Subsidiaries 81
13.1 Head Office 81
13.2 Other Locations & Subsidiaries 81
14 Financial Deals Landscape 87
14.1 PerkinElmer, Inc., Deals Volume Summary, 2007 to YTD 2013 87
15 PerkinElmer, Inc., Deals Summary By Region, 2007 to YTD 2013 88
16 PerkinElmer, Inc. Detailed Deal Summary 90
16.1 Venture Financing 90
16.1.1 Signature Genomic Labs Secures Financing From jVEN Capital 90
16.1.2 Signature Genomic Labs Secures Financing 91
16.2 Private Equity 92
16.2.1 PerkinElmer Sells Illumination And Detection Solutions Business To Veritas Capital 92
16.3 Partnerships 94
16.3.1 PerkinElmer Enters Into Licensing Agreement With Tibco Software For Tibco Spotfire 94
16.3.2 PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 96
16.3.3 Caliper Life Sciences Enters Into Licensing Agreement With Becton, Dickinson and Company 97
16.3.4 PerkinElmer Enters Into Licensing Agreement With Max Planck Innovation 98
16.3.5 PerkinElmer Enters Into Co-Marketing Agreement With Verinata Health For Verifi Test 99
16.3.6 Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 100
16.3.7 PerkinElmer Enters Into Technology Integration Agreement With Reed Elsevier 101
16.3.8 DxTerity Diagnostics Enters Into Technology Integration Agreement With Caliper Life Sciences 102
16.3.9 PerkinElmer Enters Into Distribution Agreement With Rubicon Genomics 103
16.3.10 Roche Enters Into Distribution Agreement With PerkinElmer 105
16.3.11 Roche NimbleGen Enters Into Co-Marketing Agreement With Caliper Life Sciences 106
16.3.12 Caliper Life Sciences Enters Into Co-Development Agreement With HistoRx 107
16.3.13 Caliper Life Sciences Enters Into Co-Marketing Agreement With Covaris 108
16.3.14 PerkinElmer Enters Into Co-Development Agreement With Meyer Children’s Hospital of Florence 109
16.3.15 Caliper Life Sciences Enters Into An Agreement With Seegene 110
16.3.16 PerkinElmer Enters Into An Agreement With LinaTech 111
16.3.17 Caliper Life Sciences Enters Into An Agreement With Access Genetics 112
16.3.18 PerkinElmer Completes Private Placement Of 5% Senior Notes Due 2021 For $500 Million 113
16.3.19 Perkinelmer Completes Private Placement Of Series 2008-A Senior Notes Due 2015 For $150 Million 115
16.4 Acquisition 116
16.4.1 PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech For $38 Million 116
16.4.2 PerkinElmer Completes Acquisition Of Caliper Life Sciences For $600 Million 118
16.4.3 PerkinElmer Acquires Dexela 120
16.4.4 PerkinElmer Acquires Labtronics 121
16.4.5 PerkinElmer Acquires Geospiza 122
16.4.6 PerkinElmer Acquires Chemagen Biopolymer 123
16.4.7 Caliper Life Sciences Completes Acquisition Of Cambridge Research & Instrumentation 125
16.4.8 PerkinElmer Completes Acquisition Of VisEn Medical 127
16.4.9 PerkinElmer Acquires Signature Genomic Labs 129
16.4.10 PerkinElmer Acquires Remaining 50% Stake In AB SCIEX From Danaher For $35 Million 131
16.4.11 PerkinElmer Completes Acquisition Of Sym-Bio LifeScience 133
16.4.12 PerkinElmer Completes Acquisition Of Opto Technology 134
16.4.13 PerkinElmer Acquires LabMetrix Technologies 135
16.4.14 Perkinelmer Acquires Perkinelmer India From Labindia Instruments 136
16.4.15 PerkinElmer Acquires Evotec Technologies 137
17 Recent Developments 139
17.1 Strategy And Business Planning 139
17.1.1 Nov 20, 2012: PerkinElmer Establishes New Direct Operations In Southern Africa 139
17.1.2 Jun 07, 2012: PerkinElmer To Create New Personalized Health Innovation Center of Excellence In Massachusetts, US 139
17.1.3 Feb 17, 2010: PerkinElmer Launches New Health Screening Lab In India 140
17.1.4 Aug 24, 2009: PerkinElme Launches Second Specialized GMP Services Facility 140
17.1.5 Mar 01, 2009: Perkinelmer Opens New Center Of Excellence In Singapore 141
17.2 Financial Announcements 141
17.2.1 Oct 25, 2012: PerkinElmer Reports Revenue Of $509.6m In Q3 2012 141
17.2.2 Aug 02, 2012: PerkinElmer Reports Revenue Of $521.8m In Q2 2012 142
17.2.3 Apr 26, 2012: PerkinElmer Reports Revenue Of $510.9m In Q1 2012 143
17.2.4 Feb 02, 2012: PerkinElmer Reports Revenue Of $1.9 Billion In 2011 144
17.2.5 Nov 03, 2011: PerkinElmer Reports Revenues Of $453.7m In Q3 2011 145
17.2.6 Aug 04, 2011: PerkinElmer Reports Revenues Of $479.5m In Q2 2011 146
17.2.7 May 05, 2011: PerkinElmer Reports Net Income Of $23.5m In Q1 2011 147
17.2.8 Feb 03, 2011: PerkinElmer Reports Net Income Of $383.92 Million In 2010 148
17.2.9 Nov 04, 2010: PerkinElmer Reports Sales Of $419.1 Million For Q3 2010 149
17.2.10 Aug 05, 2010: PerkinElmer Reports Net Income Of $57.64 Million In Q2 2010 150
17.2.11 May 06, 2010: PerkinElmer Reports Net Income Of $24.4 Million In Q1 2010 150
17.2.12 Feb 04, 2010: PerkinElmer Reports Net Income Of $85.6 Million In 2009 151
17.2.13 Oct 29, 2009: PerkinElmer Reports Net Income Of $13.6 Million In Q3 2009 152
17.2.14 Jul 30, 2009: PerkinElmer Reports Net Income Of $21.5 Million In Q2 2009 153
17.2.15 Apr 30, 2009: PerkinElmer Posts $10.6 Million Net Income For Q1 2009 154
17.2.16 Jan 29, 2009: PerkinElmer Reports 2008 Results 155
17.2.17 Jan 28, 2009: PerkinElmer Declares Quarterly Dividend 156
17.2.18 Jan 20, 2009: PerkinElmer To Report Q4 2008 Results 157
17.2.19 Oct 23, 2008: PerkinElmer Reports 3Q 2008 Results 157
17.2.20 Oct 22, 2008: PerkinElmer Declares Quarterly Dividend 158
17.2.21 Jul 23, 2008: PerkinElmer Reports 2Q 2008 Results 158
17.2.22 Jul 23, 2008: PerkinElmer Declares Quarterly Dividend 159
17.2.23 Jul 03, 2008: PerkinElmer To Declare Q2 2008 Results 159
17.2.24 May 28, 2008: PerkinElmer Declares Quarterly Dividend 159
17.2.25 Apr 24, 2008: PerkinElmer Reports Q1 2008 Results 159
17.2.26 Apr 14, 2008: PerkinElmer To Declare Q1 2008 Results 160
17.2.27 Jan 24, 2008: PerkinElmer Declares Q4 2007 Results 160
17.2.28 Jan 23, 2008: PerkinElmer Declares Quarterly Dividend 161
17.2.29 Oct 25, 2007: PerkinElmer Declares Q3 2007 Results 162
17.2.30 Oct 24, 2007: PerkinElmer Declares Quarterly Dividend 163
17.2.31 Jul 26, 2007: PerkinElmer Reports Q2 2007 Results 163
17.2.32 Jul 25, 2007: PerkinElmer Declares Quarterly Dividend 163
17.2.33 May 17, 2007: PerkinElmer Declares Quarterly Dividend 164
17.2.34 Apr 26, 2007: PerkinElmer Declares Q1 2007 Results 164
17.2.35 Jan 25, 2007: PerkinElmer Declares Q4 2006 Results 164
17.2.36 Jan 25, 2007: PerkinElmer Declares Quarterly Dividend 165
17.2.37 Jan 04, 2007: PerkinElmer Declares Quarterly Dividend 165
17.3 Research And Development 165
17.3.1 Dec 19, 2011: PerkinElmer’s ViaCord Collaborates With Miracle Babies To Improve Collection Of Stem Cells From Premature Births For Potential Therapeutic Use 165
17.3.2 Mar 26, 2008: PerkinElmer Opens R&D Centre In Singapore 166
17.4 Corporate Communications 167
17.4.1 Feb 01, 2012: PerkinElmer Elects Peter Barrett To Board 167
17.4.2 Jan 28, 2010: PerkinElmer Announces Retirement Of Richard F. Walsh As Senior Vice President, CAO 167
17.4.3 Jul 27, 2009: PerkinElmer Appoints Lapo Paladini As CMO 167
17.4.4 Apr 29, 2009: PerkinElmer Appoints Frank A Wilson As SVP, CAO And CFO 168
17.4.5 Apr 29, 2009: PerkinElmer Names Robert F. Friel As Chairman Of The Board Of Directors 168
17.4.6 Nov 26, 2008: PerkinElmer Appoints Vice President, Cellular Imaging And Analysis 168
17.4.7 Sep 04, 2008: PerkinElmer’s CEO To Present At UBS Best of Americas Conference 169
17.4.8 Jul 07, 2008: PerkinElmer Appoints President, Greater China Operations 169
17.4.9 May 19, 2008: PerkinElmer Announces Management Changes 169
17.4.10 Mar 24, 2008: PerkinElmer Appoints Director, Laboratory Services 170
17.4.11 Feb 25, 2008: PerkinElmer Elects New Director 170
17.4.12 Jan 23, 2008: PerkinElmer Elects New CEO 170
17.5 Legal and Regulatory 170
17.5.1 Jul 24, 2012: PerkinElmer Receives State of Connecticut Clinical Laboratory Licensure And CLIA Certificate Of Registration For Global DNA Sequencing Services 170
17.6 Government and Public Interest 171
17.6.1 Sep 19, 2011: PerkinElmer Helps Egypt’s MOHP Build World’s Largest Newborn Screening Laboratory 171
17.6.2 Apr 04, 2011: PerkinElmer Highlights New Life Sciences Discovery And In Vivo Imaging Solutions At AACR’s 2011 Annual Meeting 172
17.7 Product News 172
17.7.1 Oct 19, 2011: PerkinElmer Introduces Enhanced Software And Live Cell Imaging Capabilities For Opera High Content Screening System 172
17.7.2 Oct 03, 2011: PerkinElmer Releases HCA ImagAmp Reagent Kits To Improve High Content Screening And Analysis 173
17.7.3 Sep 28, 2011: PerkinElmer Launches Volocity 6.0 High Performance 3D Cellular Imaging Software Suite 174
17.7.4 Mar 29, 2011: PerkinElmer Introduces New Oncology Testing Service Utilizing OncoChip Microarray Technology For Faster And More Accurate Detection of Certain Cancers 174
17.7.5 Feb 28, 2011: PerkinElmer Introduces Signature Precision Panel | Prenatal Diagnostic Test For Rapid Detection Of Genetic Abnormalities During Pregnancy 175
17.7.6 Nov 16, 2010: PerkinElmer Introduces New Version Of Columbus Image Data Management And Analysis Software Solution For Microscopy 176
17.7.7 Nov 16, 2010: PerkinElmer Launches New LED Fiber Optic Illuminator Module For Endoscopy, Surgical Microscopy And Headlamp Applications 176
17.7.8 Nov 15, 2010: PerkinElmer To Launch New Digital X-Ray Flat Panel Detectors For Non-Destructive Testing At ASNT Fall Conference And Quality Testing Show 176
17.7.9 Oct 27, 2010: PerkinElmer Releases DELFIA Xpress PlGF Assay In Europe For Early Detection Of Pre-eclampsia In Pregnant Women 177
17.7.10 May 04, 2010: PerkinElmer Launches Prenatal BACs-on-Beads Assay In Europe 177
17.7.11 Apr 09, 2010: PerkinElmer Introduces LANCE Ultra cAMP Detection Kit For Screening G-Protein Coupled Receptors 178
17.7.12 Nov 03, 2009: PerkinElmer Receives FDA 510K Clearance For Newborn Screening Platform 179
17.7.13 Mar 06, 2009: PerkinElmer Announces The Launch Of Robust Atomic Absorption Spectrometer 180
17.8 Product Approvals 180
17.8.1 Nov 03, 2009: PerkinElmer Receives FDA 510K Clearance For Newborn Screening Platform 180
17.9 Other Significant Developments 181
17.9.1 May 07, 2012: PerkinElmer Announces Agreement With Macrogen To Provide Next Generation Sequencing Solutions 181
17.9.2 Oct 12, 2011: PerkinElmer’s Viacord Cord Blood Banking Business To Expand Stem Cell Harvesting Capabilities 182
17.9.3 Mar 30, 2011: PerkinElmer’s ViaCord Family Cord Blood Banking Business Offers Umbilical Cord Tissue Stem Cell Banking Services 182
17.9.4 Jan 31, 2011: PerkinElmer’s ViaCord Releases 200th Umbilical Cord Blood Unit For Stem Cell Treatment 183
17.9.5 Nov 29, 2010: PerkinElmer Re-Launches Its Former Illumination And Detection Solutions Business As Excelitas 184
17.9.6 Jan 15, 2009: PerkinElmer Signs Instrumentation Technologies Contract With Intertek 184
17.9.7 Sep 04, 2008: PerkinElmer’s CEO To Present At UBS Best of Americas Conference 185
18 Appendix 186
18.1 Research Methodology 187
18.2 Secondary Research 187
18.3 Primary Research 187
18.4 Models 188
18.5 Forecasts 188
18.6 Expert Panels 188
18.7 GlobalData Consulting 188
18.8 Currency Conversion 189
18.9 Contact Us 190
18.10 Disclaimer 190
【レポート販売概要】
■ タイトル：PerkinElmer, Inc.：市場シェア分析■ 英文：PerkinElmer, Inc. Market Share Analysis
■ 発行日：2013年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160536
■ 調査対象地域：グローバル
- ジェネリック医薬品の世界市場予測2016-2026What can be expected from the Generic Drugs Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects. Our 306-page report provides 175 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecast …
- 病院照明の世界市場予測（～2021年）：トロッファー、表面実装型ライト、手術用ランプThe hospital lighting market is projected to reach USD 7.03 Billion by 2021 from USD 5.19 Billion in 2016, at a CAGR of 6.2% from 2016 to 2021. The increasing adoption of LED based lighting products and increasing number of hospital in emerging economies are the key factor driving the market growth. Moreover, increasing government support to energy efficiency program for hospitals is contributing …
- スペインの末梢血管処置用機器市場見通し（～2021）Spain Peripheral Vascular Procedures Outlook to 2021 Summary GlobalData’s new report, "Spain Peripheral Vascular Procedures Outlook to 2021", provides key procedures data on the Spain Peripheral Vascular Procedures. The report provides procedure volumes within market segments - Aortic Open Repair Procedures, Aortic Stent Graft Procedures, Carotid Artery Embolic Protection Procedures, Deep Seated A …
- オーストリアの風力発電産業分析：Analyzing the Wind Power Industry in AustriaAs demand on finite petroleum reserves and the price of the fuels derived from them continues to rise, renewable forms of energy are becoming more cost-effective and profitable. In the forefront of this renewable revolution is harnessing the sustainable power of wind. Today it is one of the most positive developments created by the present storm of uncertainty unleashed as a result of escalating o …
- アミンの世界市場：エチレンアミン、アルキルアミン、脂肪族アミン、特殊アミン、エタノールアミンThe market size of amines is estimated to grow from USD 13.35 Billion in 2015 to USD 19.90 Billion by 2020, at an estimated CAGR of 8.3% between 2015 and 2020. Amines are used as a chelating agent, intermediate, formulator, neutralizing agent, activator, and corrosion inhibitors in various end use applications such as agricultural chemicals, cleaning products, gas treatment, personal care products …
- ガラス基板の世界市場予測（～2022年）：ホウケイ酸ガラス、シリコン、セラミック、石英ガラス、クォーツガラス基板The glass substrate market is estimated to be USD 1.49 Billion in 2017 and is projected to reach USD 1.97 Billion by 2022, at a CAGR of 5.7% between 2017 and 2022. The increasing use of LCDs in consumer durables, smart handheld devices, and automotive applications is one of the most significant factors projected to drive the growth of the glass substrate market. In addition, the growth of the semi …
- 世界及び中国のアスコルビン酸市場2015Global and China Ascorbic Acid Industry 2015 Market Research Report is a professional and depth research report on Global Ascorbic Acid industry. For overview analysis, the report introduces Ascorbic Acid basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market analy …
- トルエンの世界市場予測Toluene 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about toluene market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical part, the repo …
- ガラス用接着剤の世界市場About Glass Bonding AdhesivesGlass bonding adhesives are used for bonding glass to metal or glass to glass in numerous substrates. The most commonly used glass bonding adhesives are UV/LED curing systems, cyanoacrylates, epoxies, polyurethanes, and silicones. The global glass bonding adhesives market is segmented based on its application areas which include furniture, electronics, transportation, …
- ドイツの自動微生物検査市場2014Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500. “German Automated Microbiology Market 2014” is a new analysis of major business opportunities emerging in the German automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of in …
- 指紋センサの世界市場：スワイプセンサ、エリアセンサIn the present market scenario, security is one of the major issues of concern for various industry verticals such as banking, healthcare, defense, electronic gadgets, and government. This is due to the growing demand for secure & simplified access control and growing rate of unethical practices in various ,sectors, such as hacking of bank accounts, misuse of users’, , and so on. Security concerns …
- 扁平非小細胞肺癌：グローバル臨床試験レビュー（2014年上半期）Squamous Non-Small Cell Lung Carcinoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Squamous Non-Small Cell Lung Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Squamous Non-Small Cell Lung Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Squamous Non-Small Cell …
- エポキシ樹脂塗料の世界市場：溶剤型塗料、水性塗料、粉体塗料The epoxy coatings market is estimated to reach USD 33.97 Billion by 2021, at a CAGR of over 5.22% between 2016 and 2021. The drivers identified for the epoxy coatings market are growth in application areas, increased demand for waterborne epoxy coatings, and growing demand from developing nations. Construction is the largest application of epoxy coatings. The construction industry is driven by ri …
- 世界のエルシニア検査市場The report presents a detailed analysis of the Yersinia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Yersinia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commer …
- グローバル衣類業界におけるソーシング市場変化：ブリーフィング資料As brands and retailers set higher production standards and create ever more complex supply chains, they need to consider all the risks when switching suppliers. This month’s management briefing also looks at changes in China and other supplier countries, and technology to help track and oversee sourcing shifts.
